JP2013521763A5 - - Google Patents

Download PDF

Info

Publication number
JP2013521763A5
JP2013521763A5 JP2012553011A JP2012553011A JP2013521763A5 JP 2013521763 A5 JP2013521763 A5 JP 2013521763A5 JP 2012553011 A JP2012553011 A JP 2012553011A JP 2012553011 A JP2012553011 A JP 2012553011A JP 2013521763 A5 JP2013521763 A5 JP 2013521763A5
Authority
JP
Japan
Prior art keywords
rrna
biomarkers
campylobacter
subject
ccni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012553011A
Other languages
English (en)
Japanese (ja)
Other versions
JP6114035B2 (ja
JP2013521763A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/024415 external-priority patent/WO2011100483A1/en
Publication of JP2013521763A publication Critical patent/JP2013521763A/ja
Publication of JP2013521763A5 publication Critical patent/JP2013521763A5/ja
Application granted granted Critical
Publication of JP6114035B2 publication Critical patent/JP6114035B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012553011A 2010-02-10 2011-02-10 肺癌検出用唾液バイオマーカー Active JP6114035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30320510P 2010-02-10 2010-02-10
US61/303,205 2010-02-10
PCT/US2011/024415 WO2011100483A1 (en) 2010-02-10 2011-02-10 Salivary biomarkers for lung cancer detection

Publications (3)

Publication Number Publication Date
JP2013521763A JP2013521763A (ja) 2013-06-13
JP2013521763A5 true JP2013521763A5 (enExample) 2014-03-13
JP6114035B2 JP6114035B2 (ja) 2017-04-12

Family

ID=44368127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012553011A Active JP6114035B2 (ja) 2010-02-10 2011-02-10 肺癌検出用唾液バイオマーカー

Country Status (8)

Country Link
US (2) US9689039B2 (enExample)
EP (1) EP2534265A4 (enExample)
JP (1) JP6114035B2 (enExample)
KR (1) KR101824746B1 (enExample)
CN (1) CN102906275A (enExample)
AU (1) AU2011215789A1 (enExample)
CA (1) CA2789494C (enExample)
WO (1) WO2011100483A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3011730C (en) * 2008-09-09 2022-05-17 Somalogic, Inc. Lung cancer biomarkers and uses thereof
JP5931874B2 (ja) 2010-08-13 2016-06-08 ソマロジック・インコーポレーテッド 膵癌バイオマーカーおよびその使用
ES2402457B2 (es) * 2011-10-19 2014-01-20 Universidade De Vigo Procedimiento para el diagnóstico de derrame pleural maligno mediante la determinación de la concentración de calprotectina en líquido pleural.
US20150008314A1 (en) * 2012-01-26 2015-01-08 The Cleveland Clinic Foundation Diagnostic and prognostic biomarkers for cancer
EP3064940B1 (en) 2013-10-28 2019-07-03 Salivatech Co., Ltd. Salivary biomarker for pancreatic cancer
US10072303B2 (en) * 2014-03-28 2018-09-11 Mayo Foundation For Medical Education And Research Methods and materials for treating endometrial cancer
WO2015187855A1 (en) * 2014-06-03 2015-12-10 The Regents Of The University Of California Non-invasive gene mutation detection in lung cancer patients
WO2016097769A1 (en) * 2014-12-19 2016-06-23 Aberystwyth University A method for diagnosing lung cancer
CN104894269B (zh) * 2015-06-09 2016-03-02 广东省人民医院 基于MassARRAY质谱平台Iplex分析的肺癌基因谱检测试剂盒
US20190004051A1 (en) * 2016-01-12 2019-01-03 Arizona Board Of Regents On Behalf Of Arizona State University Plasma autoantibody biomarkers for diagnosis of lung cancer
WO2017210662A1 (en) * 2016-06-03 2017-12-07 Castle Biosciences, Inc. Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
CN106526187B (zh) * 2016-09-13 2018-04-13 浙江理工大学 一种基于Annexin A1蛋白的白血病检测试剂盒
DK3554681T3 (da) 2016-12-16 2022-03-21 Brigham & Womens Hospital Inc Fremgangsmåde til proteincorona-sensorarray til tidlig detektering af sygdomme
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
KR101833348B1 (ko) * 2016-12-26 2018-03-02 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 유방암 진단방법
KR101940426B1 (ko) * 2016-12-28 2019-01-18 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 대장종양 진단 방법
CN107202773B (zh) * 2017-06-01 2019-07-05 重庆大学 一种利用聚苯乙烯球的细胞周期散射光强模型建立方法
JP7356412B2 (ja) 2017-08-21 2023-10-04 サヴィセル ダイアグノスティック リミテッド 肺癌を検出する方法
CN108070656B (zh) * 2017-11-13 2021-11-09 深圳华大因源医药科技有限公司 肺癌标志物及其应用
CN108333375B (zh) * 2018-04-20 2020-08-11 山东省千佛山医院 肺非小细胞癌早期特异性自身抗体panel诊断试剂盒
JP7066540B2 (ja) * 2018-06-14 2022-05-13 株式会社日立製作所 デジタルpcrの測定方法および測定装置
CN108676888B (zh) * 2018-07-12 2022-01-28 吉林大学 一种肺部恶性肿瘤易感性预测试剂盒及系统
IL280880B2 (en) 2018-08-27 2025-04-01 Regeneron Pharma Using Raman Spectroscopy in Downstream Purification
AU2019374692B2 (en) 2018-11-07 2025-08-28 Seer, Inc. Compositions, methods and systems for protein corona analysis and uses thereof
EP3671213A1 (en) * 2018-12-20 2020-06-24 Kromat Muszerforgalmazó Kft. In vitro method for the diagnosis of malignant conditions
WO2020128546A1 (en) * 2018-12-20 2020-06-25 Kromat Műszerforgalmazó Kft. A simple, non-invasive method for diagnosing oral cancer
EP3946054A4 (en) 2019-03-26 2022-12-28 Seer, Inc. COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOLIQUIDS AND THEIR USES
AU2020326698A1 (en) 2019-08-05 2022-02-24 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis
KR102473361B1 (ko) * 2020-02-24 2022-12-01 한림대학교 산학협력단 기계식 인공호흡 환자의 미생물 프로파일링으로 탈관 성공률과 28일 생존율을 예측하는 방법
CN111735869A (zh) * 2020-05-29 2020-10-02 中山大学 一种蛋白质的检测试剂及检测方法
JP2023540904A (ja) 2020-08-25 2023-09-27 シアー, インコーポレイテッド タンパク質および核酸をアッセイするための組成物および方法
KR102732170B1 (ko) * 2021-05-20 2024-11-19 한국식품연구원 구강미생물 정보를 이용한 폐암의 조기진단 및 위험성 예측 방법 또는 이를 위한 조성물
CA3224202A1 (en) * 2021-06-18 2022-12-22 Polyvalor, Limited Partnership Methods and systems for interrogating a drop of saliva using raman spectroscopy
CN119979743A (zh) * 2025-04-11 2025-05-13 华中科技大学同济医学院附属协和医院 用于预测良恶性肺结节的呼出气冷凝液微生物组合、试剂盒及应用
CN120490462A (zh) * 2025-07-16 2025-08-15 成都中医药大学 一种用于肺结节的微生物筛查试剂盒及筛查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157872A0 (en) * 2001-03-12 2004-03-28 Monogen Inc A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis
CA2506066A1 (en) * 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
AU2005231101A1 (en) 2004-03-30 2005-10-20 Eastern Virginia Medical School Lung cancer biomarkers
JP2008536480A (ja) 2005-02-17 2008-09-11 ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド 癌の同定、評価、予防、および治療用組成物、キット、および方法、ならびに癌の治療法
WO2006105642A1 (en) * 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
US20080286273A1 (en) * 2007-05-02 2008-11-20 Siemens Medical Solutions Usa, Inc. Knowledge-Based Proliferation Signatures and Methods of Use
WO2009039023A2 (en) * 2007-09-18 2009-03-26 Board Of Regents Of The University Of Texas System Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast
GB0803192D0 (en) 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
WO2009154790A2 (en) 2008-06-20 2009-12-23 University Of Massachusetts Novel metastasis suppresor genes and uses thereof
US20110123441A1 (en) * 2009-10-23 2011-05-26 University Of Miami Novel greb1a monoclonal antibody

Similar Documents

Publication Publication Date Title
JP2013521763A5 (enExample)
Bonne et al. Salivary biomarker development using genomic, proteomic and metabolomic approaches
Bosch et al. Molecular tests for colorectal cancer screening
Hudler et al. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics
KR101824746B1 (ko) 폐암 검출용 타액 바이오마커
Im et al. Novel nanosensing technologies for exosome detection and profiling
Simpson et al. Proteomics-driven cancer biomarker discovery: looking to the future
JP2014508298A5 (enExample)
Roe et al. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case–control study
JP2016507723A5 (enExample)
Usó et al. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
JP2016507066A5 (enExample)
WO2008008785A3 (en) Ultra-sensitive detection of analytes
JP2016000057A5 (enExample)
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
CN115516110A (zh) 结直肠癌dna甲基化的检测方法及试剂
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
JP2017508442A5 (enExample)
JP2015505370A5 (enExample)
Wang et al. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer
JP2012501318A5 (enExample)
WO2016161088A3 (en) Biosensor system for the rapid detection of analytes
Nabih et al. The diagnostic efficacy of nectin 4 expression in ovarian cancer patients